Relationships among exercise capacity, hypertrophy, and left ventricular diastolic function in nonobstructive

Related Experiment Video

Updated: Aug 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Afonso Y Matsumoto1, Edmundo Arteaga, Barbara M Ianni

  • 1Departmnet of Cardiomyopathy, Heart Institute (InCor), University of São Paulo Medical School, São Paulo, Brazil. fymatsumoto@superig.com.br

American Heart Journal
|August 9, 2005
PubMed

Insights

Exercise capacity in nonobstructive hypertrophic cardiomyopathy (NOHCM) is linked to diastolic function, not left ventricular hypertrophy. Relaxation changes and inadequate left ventricular filling may impair exercise capacity.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology

Background:

  • Nonobstructive hypertrophic cardiomyopathy (NOHCM) presents unique challenges in understanding its impact on patient function.
  • Exercise capacity (EC) is a crucial metric for assessing functional status in cardiovascular diseases.

Purpose of the Study:

  • To investigate the interrelationships between exercise capacity, left ventricular hypertrophy (LVH), and diastolic function in patients with NOHCM.

Main Methods:

  • Echocardiography was used to assess LVH.
  • Mitral and pulmonary vein flow, along with tissue Doppler imaging, were employed to evaluate diastolic function.
  • Peak oxygen uptake (VO2) and anaerobic threshold (AT) were determined to assess EC.

Main Results:

  • No significant correlation was found between EC and LVH.
  • Peak VO2 and AT showed correlations with diastolic function parameters, specifically D and Ea/Aa.
  • Patients exhibited evidence of elevated left ventricular end-diastolic pressure despite normal filling pressures.

Conclusions:

  • Diastolic dysfunction, characterized by relaxation abnormalities and impaired left ventricular filling, appears to be a primary determinant of reduced exercise capacity in NOHCM.
  • Left ventricular hypertrophy is not directly correlated with exercise limitations in this patient cohort.
Abstract

More Related Videos

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...